Vytorin Fails to Reduce Heart Problems... Again
The ever-controversial cholesterol drug Vytorin apparently does not lower the risk of major heart valve problems, according to a report released Monday afternoon by its manufacturers, Schering-Plough Corp. and Merck & Co. Vytorin is a prescription pill containing two cholesterol-lowering medications, Zetia (ezetimibe) plus Zocor... Read more
